A new multicenter study that recently appeared on the medRxiv* preprint server in November 2020 has found a lower or equal risk of fatal coronavirus disease 2019 (COVID-19) in hypertensive patients, ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hypertension is associated with significantly increased mortality in patients with COVID-19, new ...
A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of ...
New observational data from Wuhan, China, suggest that hypertensive patients hospitalized with COVID-19 had a twofold increased risk of dying compared to those without hypertension, and that not being ...
A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of ...
Sophia Antipolis, 18 April 2012 – Treatment with an ACE inhibitor for lowering high blood pressure showed a significant mortality reduction in patients with a high prevalence of hypertension, ...
Please provide your email address to receive an email when new articles are posted on . Renin-angiotensin-aldosterone system inhibitor use in patients with hypertension and intracranial aneurysm was ...
Please provide your email address to receive an email when new articles are posted on . Renin-angiotensin-aldosterone system (RAAS) inhibitors conferred reduced risks for starting dialysis or needing ...
Hypertension is believed to be the single greatest factor influencing the development of heart failure, particularly heart failure with preserved ejection fraction, also known as diastolic heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results